CAUSES OF NEUROPATHY IN PATIENTS REFERRED AS "IDIOPATHIC NEUROPATHY"

被引:65
作者
Farhad, Khosro [1 ]
Traub, Rebecca [1 ]
Ruzhansky, Katherine M. [1 ]
Brannagan, Thomas H., III [1 ]
机构
[1] Columbia Univ, Med Ctr, Neurol Inst New York, Peripheral Neuropathy Ctr, 710 West 168th St, New York, NY 10032 USA
关键词
CIDP; diabetes; idiopathic; MGUS; neuropathy; prediabetes; IMPAIRED GLUCOSE-TOLERANCE; AUGSBURG SURVEYS S2; SENSORY NEUROPATHY; CELIAC-DISEASE; SKIN BIOPSY; POLYNEUROPATHY; PREVALENCE; SPECTRUM; RISK;
D O I
10.1002/mus.24969
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The etiology of neuropathy was idiopathic in 20%-30% of patients despite thorough investigation, based on results from the 1980s and 1990s. Since then, new etiologies have been recognized, and skin biopsy has been used to confirm small-fiber neuropathy. Methods: The authors reviewed the charts of 373 patients with idiopathic neuropathy who were referred to a neuropathy center between 2002 and 2012. Results: Among the 284 eligible patients, 93 (32.7%) remained idiopathic. The most common cause was impaired glucose metabolism (72 patients, 25.3%), including diabetes in 26 and prediabetes in 46. Other etiologies were chronic inflammatory demyelinating polyneuropathy (CIDP) in 57 (20%) and monoclonal gammopathy in 20 (7%), as well as toxic, Sjogren disease, celiac disease, other immune-mediated diseases, vitamin B-12 deficiency, amyloidosis, vitamin B-1 and B-6 deficiency, vasculitis, hypothyroidism, hereditary, Lyme disease, and antisulfatide antibody. Conclusions: The major causes of undiagnosed neuropathies were impaired glucose metabolism, CIDP, and monoclonal gammopathies. Despite thorough evaluation 32.7% remained idiopathic.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 45 条
[1]  
American Diabetes Association, 2012, DIABETES CARE S1, V35, pS12
[2]   Approach to peripheral neuropathy and neuronopathy [J].
Barohn, RJ .
SEMINARS IN NEUROLOGY, 1998, 18 (01) :7-18
[3]   DOSE-RESPONSE, COASTING, AND DIFFERENTIAL FIBER VULNERABILITY IN HUMAN TOXIC NEUROPATHY - A PROSPECTIVE-STUDY OF PYRIDOXINE NEUROTOXICITY [J].
BERGER, AR ;
SCHAUMBURG, HH ;
SCHROEDER, C ;
APFEL, S ;
REYNOLDS, R .
NEUROLOGY, 1992, 42 (07) :1367-1370
[4]   Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin [J].
Beulens, Joline W. J. ;
Hart, Huberta E. ;
Kuijs, Ron ;
Kooijman-Buiting, Antoinette M. J. ;
Rutten, Guy E. H. M. .
ACTA DIABETOLOGICA, 2015, 52 (01) :47-53
[5]   Small-fiber neuropathy/neuronopathy associated with celiac disease - Skin biopsy findings [J].
Brannagan, TH ;
Hays, AP ;
Chin, SS ;
Sander, HW ;
Chin, RL ;
Magda, P ;
Green, PHR ;
Latov, N .
ARCHIVES OF NEUROLOGY, 2005, 62 (10) :1574-1578
[6]   Current diagnosis of CIDP: the need for biomarkers [J].
Brannagan, Thomas H., III .
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 :3-13
[7]   Celiac neuropathy [J].
Chin, RL ;
Sander, HW ;
Brannagan, TH ;
Green, PHR ;
Hays, AP ;
Alaedini, A ;
Latov, N .
NEUROLOGY, 2003, 60 (10) :1581-1585
[8]   Characteristics of patients with sensory neuropathy diagnosed with abnormal small nerve fibres on skin biopsy [J].
De Sousa, E. A. ;
Hays, A. P. ;
Chin, R. L. ;
Sander, H. W. ;
Brannagan, T. H., III .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (08) :983-985
[9]   Impaired Glycemia and Diabetic Polyneuropathy The OC IG Survey [J].
Dyck, Peter J. ;
Clark, Vicki M. ;
Overland, Carol J. ;
Davies, Jenny L. ;
Pach, John M. ;
Dyck, P. James B. ;
Klein, Christopher J. ;
Rizza, Robert A. ;
Melton, L. Joseph, III ;
Carter, Rickey E. ;
Klein, Ronald ;
Litchy, William J. .
DIABETES CARE, 2012, 35 (03) :584-591
[10]   INTENSIVE EVALUATION OF REFERRED UNCLASSIFIED NEUROPATHIES YIELDS IMPROVED DIAGNOSIS [J].
DYCK, PJ ;
OVIATT, KF ;
LAMBERT, EH .
ANNALS OF NEUROLOGY, 1981, 10 (03) :222-226